News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes Todd Neale October 07, 2025
News Daily News Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients Todd Neale September 12, 2025
News Daily News HF Risks Stick Around Even When Ejection Fraction Improves Todd Neale August 01, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Daily News Sotagliflozin Reduces Ischemic Risk in SCORED Analysis Yael L. Maxwell February 25, 2025
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT L.A. McKeown December 05, 2024
News Daily News Scoring System Puts Focus on Medical Therapy Optimization in HFrEF L.A. McKeown August 13, 2024
News Daily News Acute HF Patients Live Longer When Seen by Specialists Michael O'Riordan August 09, 2024
News Daily News FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF L.A. McKeown August 05, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News Kidney Events High in Older Patients After HF Hospitalization L.A. McKeown May 30, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024